Bristol-Myers Squibb
BMY
BMY
1,597 hedge funds and large institutions have $69.4B invested in Bristol-Myers Squibb in 2016 Q4 according to their latest regulatory filings, with 203 funds opening new positions, 561 increasing their positions, 633 reducing their positions, and 102 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
1,597
Holders Change
+79
Holders Change %
+5.2%
% of All Funds
39.98%
Holding in Top 10
59
Holding in Top 10 Change
+10
Holding in Top 10 Change %
+20.41%
% of All Funds
1.48%
New
203
Increased
561
Reduced
633
Closed
102
Calls
$1.49B
Puts
$1.38B
Net Calls
+$115M
Net Calls Change
+$343M
Top Buyers
| 1 |
Dodge & Cox
San Francisco,
California
|
+$1.31B |
| 2 |
Capital World Investors
Los Angeles,
California
|
+$896M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
+$691M |
| 4 |
JP
Jana Partners
New York
|
+$226M |
| 5 |
Jennison Associates
New York
|
+$204M |
Top Sellers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$475M |
| 2 |
Morgan Stanley
New York
|
-$392M |
| 3 |
Winslow Capital Management
Minneapolis,
Minnesota
|
-$348M |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
-$275M |
| 5 |
Renaissance Technologies
New York
|
-$242M |
